Introduction
============

The non-typhi bacterium *Salmonella enterica* subspecies *enterica* serovar Ohio (*Salmonella* Ohio) is a rare human pathogen that can be acquired from livestock to cause zoonotic enterocolitis. Salmonellosis typically manifests as enterocolitis, with only rare extra-intestinal focal infections; the rates of osteomyelitis and septic arthritis due to *Salmonella* (typhi and non-typhi strains combined) are estimated to be less than 1% and 0.1% to 0.2% \[[@B1]\], respectively. Despite the reports of several cases of enterocolitis due to *Salmonella* Ohio \[[@B2]-[@B4]\], the only reported extraintestinal focal infection by this organism involved a soft tissue abscess \[[@B5]\].

Even though the prevalence of non-typhi salmonellosis in humans is increasing worldwide among patients immunocompromised due to conditions such as human immunodeficiency virus (HIV) infection, non-typhi salmonellosis remains rare in immunocompetent subjects. Although *Salmonella* species easily enter the bloodstream and may cause focal salmonellosis after occult bacteremia, routine antimicrobial therapy of immunocompetent patients with only intestinal symptoms is considered unnecessary \[[@B6]\].

Case presentation
=================

We report the case of a 44-year-old Japanese man without any noteworthy medical history (including food poisoning) except for a right tibial fracture due to a traffic accident 30 years ago. His most recent foreign travel to an endemic area (Hong Kong) was 19 years ago, and he had not noticed any gastrointestinal symptoms during that trip. He is an office worker and has no contact with livestock animals. In June 2011, he suddenly developed left knee pain that gradually worsened and therefore visited our hospital. X-rays showed no apparent bone fractures, but an MRI revealed a high-intensity area on T2-weighted images that was suggestive of a femoral bone abscess (Figure [1](#F1){ref-type="fig"}). Approximately 60mL of cloudy yellowish joint fluid was collected, and *Salmonella* (O:7 positive) was isolated. *In vitro* susceptibility testing by the broth microdilutionmethod using the MicroScan WalkAway 96SI system (Siemens, Germany) revealed susceptibility to ampicillin (minimal inhibitory concentration, \<4μg/mL), amoxicillin--clavulanic acid (\<8μg/mL), cefotaxime (\<8μg/mL), imipenem (\<1μg/mL), minocycline (2μg/mL), levofloxacin (\<1μg/mL), and sulfamethoxazole--trimethoprim (\<1μg/mL). The strain also was susceptible to nalidixic acid (30μg), according to the disc method (Becton Dickinson, Cockyesville, MD, US). Blood cultures and an HIV test were both negative. Full-body computed tomography (CT) ruled out an aortic aneurysm. In light of the diagnosis of femoral abscess with septic arthritis and the results of *in vitro* susceptibility testing, therapy with a third-generation cephalosporin (intravenous ceftriaxone 1g, once daily) was started.

![**MRI of the left knee; longitudinal scan on T2-weighted image (left panel), horizontal scan on enhanced T1-weighted image (right panel).** Polycystic bone abscess lesions were detected in the end of the left femur.](1752-1947-6-204-1){#F1}

On day 22 after presentation, he underwent arthrotomy and necrotic tissue resection. The synovium of his left knee joint was inflamed, and the distal end of his left femur contained multiple loculations that were filled with necrotic tissue. The necrotic tissue was debrided and the cavities filled with imipenem-loaded bone cement. Cultures of the necrotic tissue obtained during surgery grew O:7-positive *Salmonella*, as seen previously. To characterize the organism, we sent it to the Yokohama City Institute of Public Health for further analysis. The organism was classified as *Salmonella enterica* subspecies *enterica* serovar Ohio according to the serotype (6,7: b: l,w) assigned by using the Kauffmann--White scheme \[[@B7]\] based on agglutination with *Salmonella* O and H antigens (Denkaseiken, Tokyo, Japan). After postoperative rehabilitation, he was discharged on day 55 after presentation and received oral amoxicillin (500mg, four times daily) for six months in place of intravenous ceftriaxone.

Discussion
==========

Cases of non-typhi salmonellosis in immunocompromised patients are increasing worldwide. Most of these cases are gastrointestinal and systemic infections, and additional complications remain rare. One of the few reports from countries in southeastern Asia suggested age older than 60 years and younger than 6 years as independent risk factors for non-typhi salmonellosis \[[@B8]\]; another study from the same geographic region named age older than 50 years as a risk factor for the infectious vasculitis caused by non-typhi *Salmonella*\[[@B9]\]. Although food poisoning with *Salmonella* Ohio has occurred in Europe and Mexico \[[@B2]-[@B4]\], the organism is more prevalent in southeastern Asia, but there have been no previous clinical reports of *Salmonella* Ohio infection in Japan. One report \[[@B10]\] suggested that food poisoning due to non-typhi *Salmonella* has a very low incidence in Japan. In that report, the incidences of *Salmonella* gastroenteritis in the 'Asia Pacific, High Income' and 'Asia, East' regions were estimated to be 32 and 3600 per 100,000 person-years, respectively \[[@B10]\]. This study assigned Japan to the 'Asia Pacific, High Income' region. Another report suggests that non-typhi salmonellosis (especially serotype D) was still prevalent in Hong Kong during 1982 to 1993 \[[@B11]\]. Our patient had no history of food poisoning, and his most recent travel to another endemic country occurred 19 years before presentation. Despite the lack of microbiologic confirmation of prior infection with *Salmonella* Ohio, oral infection at some point during his residence in Japan cannot be ruled out. In-depth discussion regarding his past medical history failed to reveal any probable source of the infection. We surmise that our patient had been infected asymptomatically at some point during the preceding 19 years and that the current joint and bone infection developed long after the primary incident. The reason for, and the duration of, the asymptomatic period are currently unknown and warrant further investigation.

*Salmonella* species enter the bloodstream readily, and blood cultures should be considered whenever *Salmonella* infections are suspected or diagnosed. Routine antibiotic therapy of immunocompetent patients with only gastrointestinal symptoms of salmonellosis currently is not considered to be necessary \[[@B6]\]. However, perhaps this therapy should be provided, given the possibility of late serious sequellae, as in our patient. A report from Taiwan showed that the non-typhi *Salmonella* serovar Choleraesuis has low susceptibility to quinolones; therefore, empiric treatment with a third-generation cephalosporin should be considered \[[@B9]\]. In our patient, identifying the bacterial strain contributed to choosing the appropriate treatment for his bone infection.

Conclusions
===========

We presented a case of septic arthritis and bone abscess due to a rare pathogen, *Salmonella enterica* serovar Ohio, in a 44-year-old immunocompetent man with no recent history of travel abroad or food poisoning. Although routine antibiotic therapy of immunocompetent patients with gastrointestinal salmonellosis only is thought currently to be unnecessary, severe extra-intestinal focal infections can occur after a prolonged (for example, decades) asymptomatic period.
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